Operskalski EA, Kovacs A: HIV/HCV co-infection: pathogenesis, clinical complications, treatment, and new therapeutic technologies. Curr HIV/AIDS Rep. 2011, 8 (1): 12-22. 10.1007/s11904-010-0071-3.
Article
PubMed
PubMed Central
Google Scholar
Alatrakchi N, Koziel MJ: A tale of two viruses: hepatitis C in the age of HAART. Lancet. 2003, 362: 1687-1688. 10.1016/S0140-6736(03)14881-7.
Article
PubMed
Google Scholar
Chen SL, Morgan TR: The natural history of hepatitis C virus (HCV) infection. Int J Med Sci. 2006, 3: 47-52.
Article
PubMed
PubMed Central
Google Scholar
Global Summary of the HIV/AIDS epidemic, December 2010. [http://www.who.int/hiv/data/2011_epi_core_en.png]
Weber R, Sabin CA, Friis-Møller N, Reiss P, El-Sadr WM, Kirk O, Dabis F, Law MG, Pradier C, De Wit S, Akerlund B, Calvo G, Monforte A, Rickenbach M, Ledergerber B, Phillips AN, Lundgren JD: Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study. Arch Intern Med. 2006, 166: 1632-1641.
Article
PubMed
Google Scholar
Graham CS, Baden LR, Yu E, Mrus JM, Carnie J, Heeren T, Koziel MJ: Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis. Clin Infect Dis. 2001, 33: 562-569. 10.1086/321909.
Article
CAS
PubMed
Google Scholar
Parodi C, Belmonte L, Bare P, de Bracco MM, Ruibal-Ares B: Impact of human immune deficiency virus infection on hepatitis C virus infection and replication. Curr HIV Res. 2007, 5: 55-67. 10.2174/157016207779316341.
Article
CAS
PubMed
Google Scholar
Seeff LB: Natural history of chronic hepatitis C. Hepatology. 2002, 36: S35-S46.
Article
PubMed
Google Scholar
Qurishi N, Kreuzberg C, Lüchters G, Effenberger W, Kupfer B, Sauerbruch T, Rockstroh JK, Spengler U: Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfection. Lancet. 2003, 362 (9397): 1708-1713. 10.1016/S0140-6736(03)14844-1.
Article
CAS
PubMed
Google Scholar
Antonucci G, Goletti D, Lanini S, Girardi E, Loiacono O: HIV/HCV co-infection: putting the pieces of the puzzle together. Cell Death Differ. 2003, 10 (Suppl 1): S25-S26.
Article
PubMed
Google Scholar
Soto B, Sánchez-Quijano A, Rodrigo L, del Olmo JA, García-Bengoechea M, Hernández-Quero J, Rey C, Abad MA, Rodríguez M, Sales Gilabert M, González F, Mirón P, Caruz A, Relimpio F, Torronteras R, Leal M, Lissen E: Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis. J Hepatol. 1997, 26: 1-5.
Article
CAS
PubMed
Google Scholar
Roe B, Coughlan S, Hassan J, Grogan A, Farrell G, Norris S, Bergin C, Hall WW: Elevated serum levels of interferon-gamma-inducible protein-10 in patients coinfected with hepatitis C virus and HIV. J Infect Dis. 2007, 196: 1053-1057. 10.1086/520935.
Article
CAS
PubMed
Google Scholar
Berenguer J, Fernandez-Rodríguez A, Jimenez-Sousa MA, Cosín J, Zarate P, Micheloud D, López JC, Miralles P, Catalán P, Resino S: High plasma CXCL10 levels are associated with HCV-genotype 1, and higher insulin resistance, fibrosis, and HIV viral load in HIV/HCV coinfected patients. Cytokine. 2012, 57 (1): 25-29. 10.1016/j.cyto.2011.10.020.
Article
CAS
PubMed
Google Scholar
Larrubia JR, Benito-Martinez S, Calvino M, Sanz-de-Villalobos E, Parra-Cid T: Role of chemokines and their receptors in viral persistence and liver damage during chronic hepatitis C virus infection. World J Gastroenterol. 2008, 14: 7149-7159. 10.3748/wjg.14.7149.
Article
CAS
PubMed
PubMed Central
Google Scholar
Butera D, Marukian S, Iwamaye AE, Hembrador E, Chambers TJ, Di Bisceglie AM, Charles ED, Talal AH, Jacobson IM, Rice CM, Dustin LB: Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis C. Blood. 2005, 106: 1175-1182. 10.1182/blood-2005-01-0126.
Article
CAS
PubMed
PubMed Central
Google Scholar
García-López MA, Sánchez-Madrid F, Rodríguez-Frade JM, Mellado M, Acevedo A, García MI, Albar JP, Martínez C, Marazuela M: CXCR3 chemokine receptor distribution in normal and inflamed tissues: expression on activated lymphocytes, endothelial cells, and dendritic cells. Lab Invest. 2001, 81 (3): 409-418. 10.1038/labinvest.3780248.
Article
PubMed
Google Scholar
Helbig KJ, Ruszkiewicz A, Lanford RE, Berzsenyi MD, Harley HA, McColl SR, Beard MR: Differential expression of the CXCR3 ligands in chronic hepatitis C virus (HCV) infection and their modulation by HCV in vitro. J Virol. 2009, 83: 836-846. 10.1128/JVI.01388-08.
Article
CAS
PubMed
Google Scholar
Balagopal A, Ray SC, De Oca RM, Sutcliffe CG, Vivekanandan P, Higgins Y, Mehta SH, Moore RD, Sulkowski MS, Thomas DL, Torbenson MS: Kupffer cells are depleted with HIV immunodeficiency and partially recovered with antiretroviral immune reconstitution. Aids. 2009, 23 (18): 2397-2404. 10.1097/QAD.0b013e3283324344.
Article
CAS
PubMed
PubMed Central
Google Scholar
Frankel AD, Pabo CO: Cellular uptake of the tat protein from human immunodeficiency virus. Cell. 1988, 55: 1189-1193. 10.1016/0092-8674(88)90263-2.
Article
CAS
PubMed
Google Scholar
Casrouge A, Decalf J, Ahloulay M, Lababidi C, Mansour H, Vallet-Pichard A, Mallet V, Mottez E, Mapes J, Fontanet A, Pol S, Albert ML: Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV. J Clin Invest. 2011, 121 (1): 308-317. 10.1172/JCI40594.
Article
CAS
PubMed
Google Scholar